SCHEMBL173797

SCHEMBL173797

O=C(Nc1ccccc1C(F)(F)F)Nc1cccc2c1CCN2

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.54
KMT2A Q03164 4/20 0.54
KDM4E B2RXH2 2/20 0.54
TRPV1 Q8NER1 1/20 0.48
ALDH1A1 P00352 3/20 0.47
TSHR P16473 2/20 0.47
CYP1A2 P05177 1/20 0.46
POLB P06746 4/20 0.46
MAPK1 P28482 1/20 0.46
GRIK1 P39086 1/20 0.45
NPC1 O15118 1/20 0.45
THRB P10828 1/20 0.45
RAB9A P51151 1/20 0.45
NOX1 Q9Y5S8 1/20 0.45
CXCR2 P25025 2/20 0.45
LMNA P02545 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL175419 0.82 MAPT (0.54) MEN1KMT2ATRPV1RAB9A
SCHEMBL4569778 0.81 MEN1 (0.53) MEN1KMT2AKDM4ETRPV1ALDH1A1
SCHEMBL175205 0.81 KDR (0.58) MEN1KMT2ATRPV1ALDH1A1GRIK1
SCHEMBL175199 0.80 HTT (0.51) MEN1KMT2AALDH1A1GRIK1NPC1
SCHEMBL174238 0.80 DDX3X (0.52) MEN1KMT2AKDM4EALDH1A1POLB
SCHEMBL175017 0.78 GAA (0.56) MEN1KMT2AKDM4EALDH1A1TSHR
SCHEMBL257377 0.78 GAA (0.45) KDM4EALDH1A1CYP1A2POLBNPC1
SCHEMBL173758 0.77 SMN1; SMN2 (0.53) MEN1KMT2AKDM4EALDH1A1POLB
SCHEMBL30684831 0.75 NOTUM (0.40)
SCHEMBL3874122 0.75 NOTUM (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611806-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS Ascepion Pharmaceuticals, Inc. (CN) 2013-07-10 EP claimed
WO-2012028106-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS ASCEPION PHARMACEUTICALS, INC. (CN) 2012-03-08 WO claimed
EP-2611806-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS Ascepion Pharmaceuticals, Inc. (CN) 2013-07-10 EP disclosed
WO-2012028106-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS ASCEPION PHARMACEUTICALS, INC. (CN) 2012-03-08 WO disclosed